James Altucher:

Watch These Oracle Price Levels as Stock Surges 30% on Boosted Sales Outlook

Oracle shares soared this morning after the computing giant raised its outlook for cloud infrastructure sales and said it added several large new customers amid booming AI demand.

The company, which has struck deals with big tech customers including Amazon, Alphabet and Microsoft, said it now sees cloud infrastructure sales jumping 77% to $18 billion this fiscal year, above its June forecast of 70% growth. CEO Safra Catz told investors that the company expects to sign-up several additional multi-billion-dollar customers in coming months to push its booked cloud orders over half a billion dollars.

Leading into the company’s earnings release, Oracle shares had gained 45% so far in 2025, handily outpacing the S&P 500’s return over the same period, boosted by robust demand for its cloud infrastructure services and AI database integration tools. The stock was up 32% at $318 in recent premarket trading.

Thanks to the rise, CEO Larry Ellison has now oustripped Tesla CEO Elon Musk as the world's richest person with a net worth of $393 billion.

⇒ Read More Here

Ray Blanco:

Researchers Create 3D-Printed Artificial Skin That Allows Blood Circulation

Swedish researchers have developed two types of 3D bioprinting techniques to artificially generate thick skin that is vascularized, meaning it contains blood vessels. 

One technique produces skin that is packed with cells, and the other produces arbitrarily shaped blood vessels in the tissue. The two technologies take different approaches to the same challenge. The approaches have been outlined in two studies published in the journal Advanced Healthcare Materials.

To accomplish their goal, the researchers designed a bio-ink called “μInk” in which fibroblasts — cells that produce dermal components such as collagen, elastin, and hyaluronic acid — are cultured on the surface of small spongy gelatin grains and encased in a hyaluronic acid gel. By building up this ink three-dimensionally using a 3D printer, they were able to create a skin structure filled with high-density cells at will.

In a transplantation experiment using mice, the researchers confirmed that living cells grew inside tissue fragments made from this ink, secreting collagen and rebuilding the components of the dermis. New blood vessels also grew inside the graft, indicating that the conditions for long-term tissue fixation were met.

In the future, these technologies may represent a breakthrough in solving long-standing problems in regenerative medicine.

⇒ Read More Here

Davis Wilson:

Elon’s $2,000,000,000,000 Purchase (Will Surprise You)

What would you buy with two trillion dollars? A megayacht? A few small countries? Nothing is off limits. This is the kind of money Tesla’s board is dangling in front of Elon Musk in a newly proposed compensation package.

At Tesla’s target valuation of $8.5 trillion, the new package would give Musk control of 25% of the company and a personal fortune worth over $2 trillion.

But to unlock the full package, Musk must reach several key targets. Among the milestones, Tesla must deliver 20 million cumulative cars and produce 1 million humanoid robots by 2035. It must also have 1 million commercially operating robotaxis.

This package is well designed. The incentives are directly aligned between Musk and shareholders to the point where I could justify owning the stock for the upside alone.

For investors, the takeaway is clear: If Musk hits these targets, shareholders will see enormous value creation – a roughly 8x return over the next decade.

⇒ Read More Here